Evoke Pharma Inc. Stock
Evoke Pharma Inc. Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Evoke Pharma Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Evoke Pharma Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Evoke Pharma Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Evoke Pharma Inc. | - | 6.842% | -24.112% | -77.062% | -57.037% | -97.302% | -94.629% |
Beximco Pharmaceuticals Ltd. GDR | - | -2.326% | -3.670% | 2.439% | -4.545% | -56.250% | -24.324% |
Cellectar BioSciences Inc. | 2.560% | 11.972% | -8.092% | 127.143% | 39.474% | -74.961% | - |
SELLAS Life Sciences Group Inc | -2.710% | -10.147% | -1.610% | -7.143% | 25.333% | -80.936% | -99.667% |
Comments
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat